EM2+ ELISA: A SEROLOGICAL TEST ABLE TO PREDICT LONG TERM OUTCOME IN INOPERABLE ALVEOLAR ECHINOCOCCOSIS PATIENTS UNDER BENZIMIDAZOLE THERAPY.

(1) hepatologie

(2) WHO collaborative centre on prevention and treatment of human echinococcosis, CHU J. Minjoz, besancon, France



This item was part of the LIVER I session at Gastro 2009 UEGW/WCOG London (17th UEGW)